+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cognitive Assessment & Training in Healthcare Market by Medical Indication, Products, Assessment Techniques, Technology, End User, Deployment - Global Forecast to 2030- Product Image
Cognitive Assessment & Training in Healthcare Market by Medical Indication, Products, Assessment Techniques, Technology, End User, Deployment - Global Forecast to 2030- Product Image
Sale

Cognitive Assessment & Training in Healthcare Market by Medical Indication, Products, Assessment Techniques, Technology, End User, Deployment - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337620
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cognitive Assessment & Training in Healthcare Market grew from USD 3.11 billion in 2024 to USD 3.36 billion in 2025. It is expected to continue growing at a CAGR of 8.14%, reaching USD 4.98 billion by 2030.

Unveiling the Future of Cognitive Health Assessment

The landscape of cognitive assessment and training in healthcare is undergoing a rapid transformation driven by escalating demand for early detection of cognitive impairments, the rise of digital health solutions, and an aging global population. Healthcare providers and researchers are increasingly recognizing the critical role of objective measurement tools and personalized training programs in improving patient outcomes across developmental, neurodegenerative, and psychiatric conditions. As emerging technologies such as artificial intelligence, digital biomarkers, and telehealth applications gain traction, the market is poised for significant expansion.

This report opens by examining the current state of cognitive assessment frameworks, exploring how traditional paper-based tests are giving way to interactive digital platforms. It highlights the convergence of hardware innovations, including portable brain monitoring devices and neurofeedback systems, with advanced software offerings designed for seamless integration into clinical workflows. By setting the stage with a clear overview of market drivers, challenges, and opportunities, this introduction provides the foundation for understanding the strategic shifts shaping the future of cognitive healthcare.

Pivotal Innovations Reshaping Cognitive Training

Over the past few years, the convergence of cutting-edge technologies has catalyzed transformative shifts in how cognitive health is measured and managed. Artificial intelligence algorithms now power predictive analytics capable of identifying subtle patterns in cognitive performance, while digital biomarkers extracted from everyday smartphone interactions enable continuous remote monitoring. Telehealth platforms have broken down geographical barriers, allowing clinicians to deliver assessments and personalized training regimens to patients in underserved regions.

In parallel, regulatory agencies worldwide have begun to recognize the clinical validity of digital cognitive tools, establishing frameworks that encourage innovation while ensuring patient safety. Collaborative partnerships between technology firms, academic institutions, and healthcare providers are accelerating the development of evidence-based solutions. As a result, the industry is moving away from one-size-fits-all methodologies toward adaptive, data-driven interventions that address individual cognitive profiles and treatment goals.

Assessing the Ripple Effects of US Tariffs 2025

In early 2025, the introduction of new United States tariffs on imported cognitive assessment hardware components and related electronic subassemblies has created both challenges and strategic recalibrations across the supply chain. Manufacturers of brain monitoring devices and neurofeedback systems faced increased input costs, prompting many to reevaluate their sourcing strategies and pursue alternative suppliers in tariff-free regions. Some organizations have accelerated domestic production plans to mitigate exposure to further trade fluctuations.

These policy changes have also influenced pricing models offered to healthcare providers, with end users absorbing portions of the cost increases through subscription pricing adjustments for device leases and maintenance services. Meanwhile, software-based solution providers, benefiting from lower trade barriers, have leveraged the situation to expand their installed base by emphasizing minimal hardware dependencies. Ultimately, these shifts underscore the importance of agile supply chain management and diversified sourcing to sustain growth in a dynamic trade environment.

Deep-Dive into Market Segmentation Dynamics

When the market is studied based on medical indication it is segmented into developmental disorders encompassing attention deficit and autism spectrum, neurodegenerative conditions including Alzheimer’s and Parkinson’s, and psychiatric disorders covering anxiety and depression. Demand in the developmental disorders segment is driven by increasing awareness of early intervention, while the neurodegenerative space sees growing adoption of continuous monitoring solutions to track disease progression. Psychiatric disorders further accelerate expansion as digital cognitive training integrates with behavioral health platforms.

Evaluated by product type, the market divides into hardware-based solutions such as brain monitoring devices and neurofeedback systems and software-based offerings that deliver cognitive testing platforms and training programs. Cost pressures and ease of deployment have favored software-centric models, yet advances in wearable and portable hardware create new opportunities for hybrid solutions that combine real-time data capture with cloud analytics.

Assessment techniques span cognitive testing modules, digital biomarkers harvested from passive data streams, and neuroimaging approaches that provide high-resolution brain mapping. The growing prominence of digital biomarkers reflects a shift toward remote, continuous evaluation, augmenting traditional neuroimaging in both clinical and research settings.

From a technology standpoint, solutions are offered through mobile applications on both Android and iOS ecosystems and web-based platforms accessible via standard browsers. Android apps dominate emerging markets due to device affordability, while iOS applications maintain strong uptake in developed regions. Meanwhile, web-based solutions ensure interoperability across diverse IT infrastructures.

End-user segmentation includes the corporate sector utilizing cognitive wellness programs, educational institutions deploying screening and training for students, healthcare providers spanning clinics, hospitals, and rehabilitation centers, and research institutes driving innovation through clinical trials. Corporate and educational deployments often prioritize rapid assessments and gamified modules, whereas medical institutions demand validated, compliance-ready tools.

Finally, deployment models range from cloud-based solutions offering scalability and remote access to on-premise installations that satisfy stringent data governance requirements. Many organizations now pursue hybrid architectures to balance flexibility with control over sensitive patient information.

Regional Trends Steering Market Growth

In the Americas region, robust healthcare infrastructure and high per-capita health expenditure have propelled rapid adoption of advanced cognitive assessment and training platforms. United States and Canada lead in integrating AI-powered cognitive screening into primary care, and Latin American markets are following suit with pilot programs targeting aging populations.

Across Europe, Middle East and Africa, collaborative regulatory frameworks within the European Union have streamlined approvals for digital therapeutic devices, encouraging innovation hubs in Western Europe and Israel. In contrast, regions in the Middle East and Africa are focusing on telehealth initiatives to expand access in remote areas, often leveraging public-private partnerships.

Asia-Pacific presents a landscape of heterogeneous growth driven by government investments in digital health infrastructure, particularly in China, India and Australia. Rapid smartphone penetration and centralized healthcare networks have enabled scalable roll-out of mobile cognitive assessment applications, while telemedicine platforms bridge gaps in rural and urban care delivery.

Competitive Forces and Leading Visionaries

The competitive landscape is shaped by established cognitive test pioneers extending their portfolios with digital solutions, emerging software startups specializing in AI algorithms, and diversified medical device manufacturers incorporating neurofeedback capabilities. Leading firms differentiate through strategic partnerships with academic research centers to validate their platforms and through acquisitions that expand their global reach. Some organizations have adopted a product bundling approach, integrating cognitive assessment modules with broader telehealth ecosystems, while others focus on niche applications such as pediatric screening or senior cognitive wellness.

Cross-industry collaboration has become a hallmark of innovation, with technology giants entering the space via cloud services and analytics offerings. Meanwhile, nimble challengers leverage subscription-based pricing to gain share among mid-sized healthcare providers. As interoperability standards evolve, companies that prioritize open APIs and seamless integration with electronic health records are securing a competitive advantage.

Strategic Imperatives for Industry Leadership

Industry leaders must prioritize the integration of artificial intelligence and machine learning into their cognitive assessment platforms to deliver predictive insights and adaptive training regimens. Forming alliances with hardware manufacturers can optimize device-software interoperability and reduce time-to-market for new solutions. Embracing modular architectures will enable rapid customization for diverse clinical and non-clinical use cases while ensuring compliance with evolving data privacy regulations.

Furthermore, expanding into emerging economies through localized solutions and partnerships with regional healthcare organizations can capture untapped demand. Investing in robust post-market surveillance and real-world evidence generation will bolster product credibility and support reimbursement strategies. To sustain growth, organizations should also cultivate a patient-centric approach that emphasizes user engagement and long-term adherence.

Robust Research Framework and Methodology

This research combines qualitative interviews with leading neurologists, psychiatrists and healthcare administrators, alongside secondary analysis of peer-reviewed journals, regulatory filings and industry white papers. Market structure was validated through data triangulation, reconciling supply-side insights from device manufacturers with demand-side feedback from end users. Financial performance metrics and strategic roadmaps were examined to identify growth trajectories and competitive dynamics.

Segmentation assumptions were stress-tested against geographic, end-user and technology variables to ensure robustness. A combination of top-down and bottom-up approaches was employed to map market share across product categories and regions. Future-looking analyses were informed by policy reviews, patent filings and pipeline assessments, creating a comprehensive framework for understanding opportunities and risks.

Synthesizing Insights for Informed Decisions

The cognitive assessment and training market stands at a pivotal juncture, marked by technological breakthroughs, shifting regulatory landscapes and evolving end-user requirements. Developmental, neurodegenerative and psychiatric applications collectively drive demand for integrated hardware and software solutions, while digital biomarkers and mobile platforms redefine accessibility and scalability.

Tariff-induced supply chain challenges underscore the need for agile sourcing and localized manufacturing, even as regional growth patterns in the Americas, EMEA and Asia-Pacific highlight diverse adoption trajectories. Competitive dynamics are intensifying as established players and disruptors alike vie for leadership through partnerships, acquisitions and technology investments.

Decision-makers must navigate this complexity by anchoring strategies in empirical evidence, embracing interoperability and maintaining a clear patient-centric focus. By aligning innovation roadmaps with regulatory trends and regional needs, stakeholders can capitalize on the transformative potential of cognitive healthcare solutions.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Medical Indication
    • Developmental Disorders
      • Attention Deficit
      • Autism Spectrum
    • Neurodegenerative
      • Alzheimer's
      • Parkinson's
    • Psychiatric Disorders
      • Anxiety
      • Depression
  • Products
    • Hardware-Based Solutions
      • Brain Monitoring Devices
      • Neurofeedback Devices
    • Software-Based Solutions
  • Assessment Techniques
    • Cognitive Testing
    • Digital Biomarkers
    • Neuroimaging
  • Technology
    • Mobile Applications
      • Android Apps
      • iOS Apps
    • Web-Based Solutions
  • End User
    • Corporate Sector
    • Educational Institutions
    • Healthcare Providers
      • Clinics
      • Hospitals
      • Rehabilitation Centers
    • Research Institutes
  • Deployment
    • Cloud-Based Solutions
    • On-Premise Solutions
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Altoida, Inc.
  • Brain Resource Company
  • BrainCheck, Inc.
  • Cambridge Cognition Ltd.
  • Clario
  • CNS Vital Signs, LLC
  • CogniFit Ltd.
  • Cogstate Ltd.
  • Dividat, Inc.
  • eIntegrity Healthcare
  • Elevate Labs Inc.
  • Impact Applications Inc
  • Koninklijke Philips N.V.
  • Linus Health, Inc.
  • Lumos Labs, Inc.
  • Medical Protection Society Limited
  • Pearson PLC
  • Posit Science Corporation
  • Re:Cognition Health Limited
  • Rosetta Stone Inc.
  • Signant Health Holding Corp.
  • Synaptic Labs Ltd.
  • VoxNeuro Inc.
  • WCG Clinical, Inc
  • Welldoing Limited

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cognitive Assessment & Training in Healthcare Market, by Medical Indication
8.1. Introduction
8.2. Developmental Disorders
8.2.1. Attention Deficit
8.2.2. Autism Spectrum
8.3. Neurodegenerative
8.3.1. Alzheimer's
8.3.2. Parkinson's
8.4. Psychiatric Disorders
8.4.1. Anxiety
8.4.2. Depression
9. Cognitive Assessment & Training in Healthcare Market, by Products
9.1. Introduction
9.2. Hardware-Based Solutions
9.2.1. Brain Monitoring Devices
9.2.2. Neurofeedback Devices
9.3. Software-Based Solutions
10. Cognitive Assessment & Training in Healthcare Market, by Assessment Techniques
10.1. Introduction
10.2. Cognitive Testing
10.3. Digital Biomarkers
10.4. Neuroimaging
11. Cognitive Assessment & Training in Healthcare Market, by Technology
11.1. Introduction
11.2. Mobile Applications
11.2.1. Android Apps
11.2.2. iOS Apps
11.3. Web-Based Solutions
12. Cognitive Assessment & Training in Healthcare Market, by End User
12.1. Introduction
12.2. Corporate Sector
12.3. Educational Institutions
12.4. Healthcare Providers
12.4.1. Clinics
12.4.2. Hospitals
12.4.3. Rehabilitation Centers
12.5. Research Institutes
13. Cognitive Assessment & Training in Healthcare Market, by Deployment
13.1. Introduction
13.2. Cloud-Based Solutions
13.3. On-Premise Solutions
14. Americas Cognitive Assessment & Training in Healthcare Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Cognitive Assessment & Training in Healthcare Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Cognitive Assessment & Training in Healthcare Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Altoida , Inc.
17.3.2. Brain Resource Company
17.3.3. BrainCheck, Inc.
17.3.4. Cambridge Cognition Ltd.
17.3.5. Clario
17.3.6. CNS Vital Signs, LLC
17.3.7. CogniFit Ltd.
17.3.8. Cogstate Ltd.
17.3.9. Dividat, Inc.
17.3.10. eIntegrity Healthcare
17.3.11. Elevate Labs Inc.
17.3.12. Impact Applications Inc
17.3.13. Koninklijke Philips N.V.
17.3.14. Linus Health, Inc.
17.3.15. Lumos Labs, Inc.
17.3.16. Medical Protection Society Limited
17.3.17. Pearson PLC
17.3.18. Posit Science Corporation
17.3.19. Re:Cognition Health Limited
17.3.20. Rosetta Stone Inc.
17.3.21. Signant Health Holding Corp.
17.3.22. Synaptic Labs Ltd.
17.3.23. VoxNeuro Inc.
17.3.24. WCG Clinical, Inc
17.3.25. Welldoing Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET MULTI-CURRENCY
FIGURE 2. COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET MULTI-LANGUAGE
FIGURE 3. COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2024 VS 2030 (%)
FIGURE 18. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ATTENTION DEFICIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY AUTISM SPECTRUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ALZHEIMER'S, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PARKINSON'S, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ANXIETY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY BRAIN MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEUROFEEDBACK DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY SOFTWARE-BASED SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY COGNITIVE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DIGITAL BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEUROIMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MOBILE APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ANDROID APPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY IOS APPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY WEB-BASED SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY CORPORATE SECTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY EDUCATIONAL INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY CLOUD-BASED SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ON-PREMISE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 73. CANADA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 74. CANADA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 75. CANADA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, 2018-2030 (USD MILLION)
TABLE 76. CANADA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 77. CANADA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 78. CANADA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 79. CANADA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 80. CANADA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. CANADA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 82. CANADA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. CANADA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 84. CANADA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 85. MEXICO COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 86. MEXICO COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 87. MEXICO COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, 2018-2030 (USD MILLION)
TABLE 88. MEXICO COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 90. MEXICO COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 91. MEXICO COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 92. MEXICO COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. MEXICO COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 94. MEXICO COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. MEXICO COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 96. MEXICO COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 146. GERMANY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 147. GERMANY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 148. GERMANY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 150. GERMANY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 151. GERMANY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 152. GERMANY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 153. GERMANY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 154. GERMANY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 155. GERMANY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. GERMANY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 157. GERMANY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 158. FRANCE COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 159. FRANCE COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 160. FRANCE COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, 2018-2030 (USD MILLION)
TABLE 161. FRANCE COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 162. FRANCE COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 163. FRANCE COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 164. FRANCE COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 165. FRANCE COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. FRANCE COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 167. FRANCE COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. FRANCE COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 169. FRANCE COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 182. ITALY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 183. ITALY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 184. ITALY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, 2018-2030 (USD MILLION)
TABLE 185. ITALY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 186. ITALY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 187. ITALY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 188. ITALY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 189. ITALY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. ITALY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 191. ITALY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. ITALY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 193. ITALY COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 194. SPAIN COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 195. SPAIN COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 196. SPAIN COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, 2018-2030 (USD MILLION)
TABLE 197. SPAIN COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 198. SPAIN COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 199. SPAIN COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 200. SPAIN COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 201. SPAIN COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. SPAIN COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 203. SPAIN COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. SPAIN COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 205. SPAIN COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 230. SOUTH AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, 2018-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 234. SOUTH AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 242. DENMARK COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 243. DENMARK COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 244. DENMARK COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, 2018-2030 (USD MILLION)
TABLE 245. DENMARK COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 246. DENMARK COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 247. DENMARK COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 248. DENMARK COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY ASSESSMENT TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 249. DENMARK COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. DENMARK COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 251. DENMARK COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. DENMARK COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 253. DENMARK COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 254. NETHERLANDS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY MEDICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 255. NETHERLANDS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY DEVELOPMENTAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 256. NETHERLANDS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY NEURODEGENERATIVE, 2018-2030 (USD MILLION)
TABLE 257. NETHERLANDS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE, BY HARDWARE-BASED SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS COGNITIVE ASSESSMENT & TRAINING IN HEALTHCARE MARKET SIZE,

Companies Mentioned

The companies profiled in this Cognitive Assessment & Training in Healthcare market report include:
  • Altoida , Inc.
  • Brain Resource Company
  • BrainCheck, Inc.
  • Cambridge Cognition Ltd.
  • Clario
  • CNS Vital Signs, LLC
  • CogniFit Ltd.
  • Cogstate Ltd.
  • Dividat, Inc.
  • eIntegrity Healthcare
  • Elevate Labs Inc.
  • Impact Applications Inc
  • Koninklijke Philips N.V.
  • Linus Health, Inc.
  • Lumos Labs, Inc.
  • Medical Protection Society Limited
  • Pearson PLC
  • Posit Science Corporation
  • Re:Cognition Health Limited
  • Rosetta Stone Inc.
  • Signant Health Holding Corp.
  • Synaptic Labs Ltd.
  • VoxNeuro Inc.
  • WCG Clinical, Inc
  • Welldoing Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.36 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.98 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Cognitive Assessment & Training Market by Products, Technology, Cognitive Games, Application, End User, Deployment Type - Global Forecast to 2030 - Product Image

Cognitive Assessment & Training Market by Products, Technology, Cognitive Games, Application, End User, Deployment Type - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Cognitive Assessment and Training Market Report by Assessment Type, Component, Application, End-User Sector, and Region 2024-2032 - Product Image

Cognitive Assessment and Training Market Report by Assessment Type, Component, Application, End-User Sector, and Region 2024-2032

  • Report
  • 146 Pages
  • Global
From
Cognitive Assessment and Training - Global Strategic Business Report - Product Image

Cognitive Assessment and Training - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Cognitive Assessment and Training in Healthcare Market Report 2025 - Product Image

Cognitive Assessment and Training in Healthcare Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Cognitive Assessment and Training Market Report 2025 - Product Image

Cognitive Assessment and Training Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.